Healthcare Brochure Expediting Virtual Clinical Trials in a Post COVID World Personal assessment and no human interaction with patients are one of the basic differences between traditional trials and virtual trials. This is why Clinical Research Organizations (CROs) and Pharma are supporting COVID rescue studies and operationalizing non-COVID studies in a remote setting. Virtual is set to become the norm in clinical trials & real-world studies. Organizations are working towards developing custom support to mobile health that enables digital patient engagement and adherence. However, according to the current scenario, following are some of the issues from a virtual clinical trial enablement perspective: Access to Sites: COVID-19 has made most of the sites inaccessible. Traveling to sites could be detrimental if exposed to COVID-19. Hence, virtual trials and remote monitoring of patients has gained precedence. Protocol Adherence: Supporting patients with adherence and treatment continuity and adapting the clinical trials protocol to mitigate the impact of COVID-19 has become crucial. Patient Retention: Lack of comprehensive patient data leads to inefficient case management and poor patient retention. Fragmented Systems of Collaboration: Dealing with multiple systems and stakeholders during trials impacts patient experience significantly.